Your session is about to expire
← Back to Search
Mobile-device, plasticity-based adaptive cognitive treatment for Depression
Study Summary
This trial is investigating a new medical application which could help manage a patient's medication. They are testing how well the application works and if patients would be willing to use it.
- Depression
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What population is eligible for inclusion in this research?
"This clinical trial is looking for 40 people aged 18 to 60 that suffer from melancholia. Eligible participants should have the necessary motor control and sensory capacity needed to interact with a computer or mobile device, be willing to communicate via email, possess wireless Internet access, and score at least 9 on the Patient Health Questionnaire-9 (PHQ-9). Additionally, those taking psychotropics or participating in therapy will not be excluded."
Is the eligibility criteria for participants of this research limited to those over twenty years old?
"As specified in the inclusion criteria, participants must range between 18 to 60 years of age. Additionally, there are 106 trials for minors and 594 studies that cater to senior citizens."
Is enrollment for this research still open?
"Affirmative. According to the clinicaltrials.gov website, this medical trial which was initially published on October 1st 2017 is actively seeking participants. Forty individuals are required from a single site for participation in the study and its details were most recently updated on September 8th 2022."
To what extent is the research study population being impacted by this intervention?
"Affirmative. According to the information shared on clinicaltrials.gov, this research endeavour was posted on October 1st 2017 and is actively recruiting participants. At the moment, 40 people need to be enrolled at one medical site."
Share this study with friends
Copy Link
Messenger